In Vivo CAR Monocytes Show Efficacy in Mice

Abstract Preclinical data presented at the Society for Immunotherapy of Cancer Annual Meeting show the potential of cancer-targeted myeloid cells, reprogrammed in the body through the use of chimeric antigen receptor–encoding mRNA encapsulated in lipid nanoparticles, to shrink metastases and suppress tumor growth.